Laura Aitken

Dr. Laura Aitken is Institute Manager at the School of Chemistry, University of St Andrews, UK. She works within the Biomedical Sciences Research Complex, focusing on pharmacology, neurodegenerative diseases, and mitochondrial dysfunction.

• Alzheimer's Disease
• Mitochondrial Disorders
• Drug Discovery
• Enzyme Inhibition

Her research involves collaborations across pharmacology, biochemistry, and molecular biology, with recent work on 17β-HSD10 inhibitors for Alzheimer's and cancer therapies. She has secured grants from the Medical Research Council and Wellcome Trust, including a 2019 ISSF3 project extension.

Key publications highlight her contributions to high-throughput screening, benzothiazole-based ureas, and mechanisms of neuronal protein dysfunction. She supervises research teams and contributes to datasets on mitochondrial morphology and Alzheimer's treatments.